Skip to content
10-Q/A

Quarterly Report

Grace Therapeutics, Inc. GRCE

0001140361-25-042491

← back to feed
Filed
Nov 17, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated Q2 2026 · Nov 13, 2025 15.47M sh